When I first valued prima for long term investment I only had dedredon as a comparator for thisr ather new technology.
So looking fwd to what the future may hold I was looking at 5bil as a potential target making prr $5 based on successful FDA approval. With absolute hope of 8-10bil long term
Now what can we expect? With dendredon at 1-2bil. We are only looking at $1-2 after FDA approval.
Can anyone help me justify anything better than what I'm valuing with risk still there of a failure? Without telling me it's still not a bad target and that dndn will sort themselves out in the current environment.
Tough times for all coming I believe
When I first valued prima for long term investment I only had...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
-0.020(5.63%) |
Mkt cap ! $508.4M | |||
| Open | High | Low | Value | Volume |
| 35.0¢ | 35.8¢ | 33.5¢ | $1.217M | 3.495M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 80427 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 183494 | 1 |
View Market Depth
| Last trade - 15.59pm 17/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |